|
1
|
Harvey KB, Bothe A Jr and Blackburn GL:
Nutritional assessment and patient outcome during oncological
therapy. Cancer. 43:2065–2069. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Argiles JM, Alvarez B and Lopez-Soriano
FJ: The metabolic basis of cancer cachexia. Med Res Rev.
17:477–498. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Argiles JM and Lopez-Soriano FJ: The
ubiquitin-dependent proteolytic pathway in skeletal muscle: its
role in pathological states. Trends Pharmacol Sci. 17:223–226.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanchis D, Busquets S, Alvarez B, Ricquier
D, Lopez-Soriano FJ and Argiles JM: Skeletal muscle UCP2 and UCP3
gene expression in a rat cancer cachexia model. FEBS Lett.
436:415–418. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Royen M, Carbo N, Busquets S, et al:
DNA fragmentation occurs in skeletal muscle during tumor growth: A
link with cancer cachexia? Biochem Biophys Res Commun. 270:533–537.
2000.PubMed/NCBI
|
|
6
|
Lee SJ and McPherron AC: Myostatin and the
control of skeletal muscle mass. Curr Opin Genet Dev. 9:604–607.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma M, Langley B, Bass J and Kambadur
R: Myostatin in muscle growth and repair. Exerc Sport Sci Rev.
29:155–158. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsuchida K: Targeting myostatin for
therapies against muscle-wasting disorders. Curr Opin Drug Discov
Devel. 11:487–494. 2008.PubMed/NCBI
|
|
9
|
McPherron AC, Lawler AM and Lee SJ:
Regulation of skeletal muscle mass in mice by a new TGF-beta
superfamily member. Nature. 387:83–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elkasrawy MN and Hamrick MW: Myostatin
(GDF-8) as a key factor linking muscle mass and bone structure. J
Musculoskelet Neuronal Interact. 10:56–63. 2010.PubMed/NCBI
|
|
11
|
Lee SJ: Sprinting without myostatin: a
genetic determinant of athletic prowess. Trends Genet. 23:475–477.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SJ: Regulation of muscle mass by
myostatin. Annu Rev Cell Dev Biol. 20:61–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson SB, Goldberg AL and Whitman M:
Identification of a novel pool of extracellular pro-myostatin in
skeletal muscle. J Biol Chem. 283:7027–7035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hill JJ, Davies MV, Pearson AA, et al: The
myostatin propeptide and the follistatin-related gene are
inhibitory binding proteins of myostatin in normal serum. J Biol
Chem. 277:40735–40741. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo T, Jou W, Chanturiya T, Portas J,
Gavrilova O and McPherron AC: Myostatin inhibition in muscle, but
not adipose tissue, decreases fat mass and improves insulin
sensitivity. PLoS One. 4:e49372009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wolfman NM, McPherron AC, Pappano WN, et
al: Activation of latent myostatin by the BMP-1/tolloid family of
metalloproteinases. Proc Natl Acad Sci USA. 100:15842–15846. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SJ: Genetic analysis of the role of
proteolysis in the activation of latent myostatin. PLoS One.
3:e16282008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
De Caestecker M: The transforming growth
factor-beta superfamily of receptors. Cytokine Growth Factor Rev.
15:1–11. 2004.
|
|
19
|
Rodino-Klapac LR, Haidet AM, Kota J, Handy
C, Kaspar BK and Mendell JR: Inhibition of myostatin with emphasis
on follistatin as a therapy for muscle disease. Muscle Nerve.
39:283–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Allendorph GP, Vale WW and Choe S:
Structure of the ternary signaling complex of a TGF-beta
superfamily member. Proc Natl Acad Sci USA. 103:7643–7648. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steelman CA, Recknor JC, Nettleton D and
Reecy JM: Transcriptional profiling of myostatin-knockout mice
implicates Wnt signaling in postnatal skeletal muscle growth and
hypertrophy. FASEB J. 20:580–582. 2006.PubMed/NCBI
|
|
22
|
Joulia-Ekaza D and Cabello G: The
myostatin gene: physiology and pharmacological relevance. Curr Opin
Pharmacol. 7:310–315. 2007. View Article : Google Scholar
|
|
23
|
Whittemore LA, Song K, Li X, et al:
Inhibition of myostatin in adult mice increases skeletal muscle
mass and strength. Biochem Biophys Res Commun. 300:965–971. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Durieux AC, Amirouche A, Banzet S, et al:
Ectopic expression of myostatin induces atrophy of adult skeletal
muscle by decreasing muscle gene expression. Endocrinology.
148:3140–3147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McFarlane C, Plummer E, Thomas M, et al:
Myostatin induces cachexia by activating the ubiquitin proteolytic
system through an NF-κB-independent, FoxO1-dependent mechanism. J
Cell Physiol. 209:501–514. 2006.PubMed/NCBI
|
|
26
|
Stock MJ and Rothwell NJ: Effects of
β-adrenergic agonists on metabolism and body composition. Control
and manipulation of Animal Growth. Buttery PJ, Hayes NB and Lindsay
DB: Butterworths; London: pp. 249–257. 1985
|
|
27
|
Kim YS and Sainz RD: Beta-adrenergic
agonists and hypertrophy of skeletal muscles. Life Sci. 50:397–407.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Agbenyega ET and Wareham AC: Effect of
clenbuterol on skeletal muscle atrophy in mice induced by the
glucocorticoid dexamethasone. Comp Biochem Physiol Comp Physiol.
102:141–145. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rajab P, Fox J, Riaz S, Tomlinson D, Ball
D and Greenhaff PL: Skeletal muscle myosin heavy chain isoforms and
energy metabolism after clenbuterol treatment in the rat. Am J
Physiol Regul Integr Comp Physiol. 279:R1076–R1081. 2000.PubMed/NCBI
|
|
30
|
Hinkle RT, Hodge KM, Cody DB, Sheldon RJ,
Kobilka BK and Isfort RJ: Skeletal muscle hypertrophy and
anti-atrophy effects of clenbuterol are mediated by the
beta2-adrenergic receptor. Muscle Nerve. 25:729–734. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wineski LE, von Deutsch DA, Abukhalaf IK,
Pitts SA, Potter DE and Paulsen DF: Muscle-specific effects of
hindlimb suspension and clenbuterol in mature male rats. Cells
Tissues Organs. 171:188–198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Busquets S, Figueras MT, Fuster G, et al:
Anticachectic effects of formoterol: a drug for potential treatment
of muscle wasting. Cancer Res. 64:6725–6731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tessitore L, Costelli P, Bonetti G and
Baccino FM: Cancer cachexia, malnutrition, and tissue protein
turnover in experimental animals. Arch Biochem Biophys. 306:52–58.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gonzalez-Cadavid NF, Taylor WE, Yarasheski
K, et al: Organization of the human myostatin gene and expression
in healthy men and HIV-infected men with muscle wasting. Proc Natl
Acad Sci USA. 95:14938–14943. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Costelli P, Muscaritoli M, Bonetto A, et
al: Muscle myostatin signalling is enhanced in experimental cancer
cachexia. Eur J Clin Invest. 38:531–538. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Joulia-Ekaza D and Cabello G: Myostatin
regulation of muscle development: molecular basis, natural
mutations, physiopathological aspects. Exp Cell Res. 312:2401–2414.
2006. View Article : Google Scholar
|
|
38
|
Kollias HD and McDermott JC: Transforming
growth factor-beta and myostatin signaling in skeletal muscle. J
Appl Physiol. 104:579–587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shimasaki S, Koga M, Esch F, et al:
Primary structure of the human follistatin precursor and its
genomic organization. Proc Natl Acad Sci USA. 85:4218–4222. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aoki MS, Soares AG, Miyabara EH, Baptista
IL and Moriscot AS: Expression of genes related to myostatin
signaling during rat skeletal muscle longitudinal growth. Muscle
Nerve. 40:992–999. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ouchi N, Oshima Y, Ohashi K, et al:
Follistatin-like 1, a secreted muscle protein, promotes endothelial
cell function and revascularization in ischemic tissue through a
nitric-oxide synthase-dependent mechanism. J Biol Chem.
283:32802–32811. 2008. View Article : Google Scholar
|
|
42
|
Cowling BS, McGrath MJ, Nguyen MA, et al:
Identification of FHL1 as a regulator of skeletal muscle mass:
implications for human myopathy. J Cell Biol. 183:1033–1048. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zamora E, Lupon J, Simo R and Galan A:
Myostatin serum levels in heart failure. Eur J Heart Fail.
12:1379author reply 1379–1380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Llovera M, Carbo N, Lopez-Soriano J, et
al: Different cytokines modulate ubiquitin gene expression in rat
skeletal muscle. Cancer Lett. 133:83–87. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Llovera M, Garcia-Martinez C, Agell N, et
al: Ubiquitin and proteasome gene expression is increased in
skeletal muscle of slim AIDS patients. Int J Mol Med. 2:69–73.
1998.PubMed/NCBI
|
|
46
|
Llovera M, Garcia-Martinez C,
Lopez-Soriano J, et al: Role of TNF receptor 1 in protein turnover
during cancer cachexia using gene knockout mice. Mol Cell
Endocrinol. 142:183–189. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Llovera M, Garcia-Martinez C, Agell N,
Lopez-Soriano FJ and Argiles JM: Muscle wasting associated with
cancer cachexia is linked to an important activation of the
ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer.
61:138–141. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Garcia-Martinez C, Llovera M, Agell N,
Lopez-Soriano FJ and Argiles JM: Ubiquitin gene expression in
skeletal muscle is increased by tumour necrosis factor-alpha.
Biochem Biophys Res Commun. 201:682–686. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Llovera M, Garcia-Martinez C, Agell N,
Marzabal M, Lopez-Soriano FJ and Argiles JM: Ubiquitin gene
expression is increased in skeletal muscle of tumour-bearing rats.
FEBS Lett. 338:311–318. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schneyer A, Tortoriello D, Sidis Y,
Keutmann H, Matsuzaki T and Holmes W: Follistatin-related protein
(FSRP): a new member of the follistatin gene family. Mol Cell
Endocrinol. 180:33–38. 2001. View Article : Google Scholar : PubMed/NCBI
|
